Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

68.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
From ANI Pharmaceuticals, Inc.
Via Business Wire
Looking Into ANI Pharmaceuticals's Return On Capital Employed
Benzinga Pro data, ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 sales of $48.62 million. Earnings fell to a loss of $15.55 million, resulting in a 610.77% decrease from last... 
Via Benzinga
ANI Pharma's Purified Cortrophin Gel Application Under FDA Review
The FDA has accepted ANI Pharmaceuticals Inc's (NASDAQ: ANIP) supplemental marketing application for Purified Cortrophin Gel. The application seeks approval... 
Via Benzinga
Exposures Product Safety
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript
ANIP earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: ANI Pharmaceuticals Q2 Earnings
Shares of ANI Pharmaceuticals (NASDAQ:ANIP) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share fell 2.90% year over year to $0.67,... 
Via Benzinga
ANI Pharmaceuticals Reports Second Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
From ANI Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript
ANIP earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
ANI Pharmaceuticals Reports First Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
Earnings Outlook for ANI Pharmaceuticals
On Friday, May 07, ANI Pharmaceuticals (NASDAQ:ANIP) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And... 
Via Benzinga
ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.